The 41st Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

Event Date:
4 – 5 December 2020
Location:
Virtual Meeting
View ProgramView Program

The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development. Richmond Pharmacology’s CEO, Jorg Taubel M.D. will be presenting three posters covering the following themes:

  • Meta-analysis of the effect of a meal on QTcF
  • Effect of Glucose Alone and in Collaboration with Moxifloxacin on Cardiac Repolaration in Male and Female Patents with Type I Diabetes
  • Effects of Progesterone and Estradiol on Subintervals over the Course of a Menstrual Cycle

Learn more about our Japanese Bridging Studies here or by using the View Publications link below.

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Novel rate-controlled fentanyl patch shows promise in phase I clinical trial

April 1, 2021
Our expertise in ethnic differences and access to over 12,000 first generation Japanese volunteers accelerated our ability to provide robust clinical trial data to support future applications of new chronic pain medicines to the Japanese drug market.
Read more

A new era for UK-Japanese scientific relations

March 23, 2021
Dr Taubel uses his experience of conducting more than 60 Japanese bridging studies to explain why the deal is of strategic importance to the UK and highlights the scientific requirements for conducting successful Japanese trials abroad
Read more

Richmond Pharmacology’s local MP Neil Coyle calls on the Government to evaluate the potential of using Clinical Research Organisations.

February 3, 2021
Richmond Pharmacology has offered its services to the Government and the NHS as an additional vaccine site in London
Read more